MPTP-Induced Parkinsonian Syndromes in Humans and Animals

This publication has 30 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys
  Life Sciences, 1985
• Inhibition of [3H] MPTP binding to rat brain by pargyline.
  Biochemical Pharmacology, 1984
• Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP
  European Journal of Pharmacology, 1984
• Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
  European Journal of Pharmacology, 1984
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  Proceedings of the National Academy of Sciences, 1983
• (-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson s Disease
  Published by S. Karger AG ,1982
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979
• A mechanism of paraquat toxicity in mice and rats
  Toxicology and Applied Pharmacology, 1976
• Superoxide Dismutases
  Annual Review of Biochemistry, 1975